Donors' fatigue hits Leong Sze Hian as 2nd fundraiser round loses steam

Apr 27, 2021 | 🚀 Fathership

Last month (Mar 24), the High Court ordered activist blogger Leong Sze Hian to pay Prime Minister Lee Hsien Loong $133,000 for defamation.

Leong was sued for sharing, on his Facebook page, an article from the Malaysian news site The Coverage that falsely linked Prime Minister Lee Hsien Loong (PM Lee) to the 1Malaysia Development Berhad (1MDB) corruption scandal in Malaysia.

The sum includes $100,000 in general damages and $33,000 in aggravated damages.

1st fundraiser by Leong Sze Hian raised over $100K

In response to the High Court ruling, Leong started a fundraiser the following day (Mar 25).

By the 11th day, 2,065 netizens contributed to the crowdfunding efforts, raising $133,082 in total.

Lee Hsien Yang, the brother of PM Lee, was one of the first few donors, as revealed by Leong. He did not disclose how much was donated.

Court orders Leong Sze Hian to pay another $130K for legal costs

In early April (Apr 15), the High Court slapped another bill to the tune of $129,327 for legal costs and disbursements.

Leong appealed once more on his Facebook for help from “courageous fellow Singaporeans”, as did his lawyer, opposition leader Lim Tean.

2nd fundraiser loses steam

After 11 days (Apr 27), Leong revealed he had only raised $48,090 from 707 donors, a 60% drop from his 1st fundraiser based on the same period, signaling donors' fatigue.


Back in November 2018, Leong shared an article from Malaysian website The Coverage on his Facebook page.

The post by Leong had no accompanying caption.

The article contained false claims about PM Lee and the 1MDB investigation.

The Coverage provided a link to something it called Straights Review, which led to an article published on Nov. 5, 2018 by anti-establishment website, States Times Review (STR).

STR did not provide any kind of evidence for its claims.

The Singapore High Commission in Malaysia called the claims "fake" and "clearly libellous".

According to The Straits Times, the article shared by Leong was visible to the public on his Facebook page from Nov. 7 to Nov. 10, 2018.

Justice Aedit Abdullah found that the false claims suggested that PM Lee was, "at the very least, involved in serious and dishonest criminal activity", and that Leong could not "reasonably claim that the defamatory words did not impugn character".

Leong, the judge said, had "published" the article as his post was hyperlinked to it, and he made it accessible as it was part of his Facebook post.

The judge also said that the link to the article, along with a headline and photo, was the only substantive content of the post and it would therefore be artificial to draw a "bright-line" distinction between the article and post.

During the defamation trial, Leong did not take the witness stand to explain himself.

His lawyer Lim Tean told the court that he did not think it was necessary for Mr Leong to take the stand since there was no case to answer prompting PM Lee's lawyer to say Leong has "turned tail" from the fight.

Lim said: "We are very satisfied that we have sufficient submissions from the plaintiff to meet our pleaded case," said Mr Lim. "The defendant's evidence, therefore, cannot assist."

S'pore firm develops first Omicron-specific testing kit

Dec 06, 2021 | 🚀 Fathership
Home-grown biotechnology firm BioAcumen Global has launched Singapore's first Omicron-specific Covid-19 polymerase chain reaction (PCR) kit.

This means that a person taking the test will receive one of three results: Covid-19 positive and Omicron positive; Covid-19 positive and Omicron negative; or Covid-19 and Omicron negative.

Currently, PCR kits here that are capable of detecting Omicron require an additional gene sequencing step to confirm the specific variant. This takes an additional day.

Some PCR kits, such as those currently in use by medical technology firm Acumen Diagnostics and biotech firm MiRXES, are able to detect both the Delta and the Omicron strains, but to confirm if a positive case has been infected by Omicron, gene sequencing is necessary.

Mr Jimmy Toh, director of BioAcumen Global, said: "We are looking at ways to cut down the steps and time needed to run this test. This is crucial, especially at the borders where accurate tests need to be done on-site. There is no time to wait on sequencing results to know if a positive sample is infected with Omicron."

Mass production of the kit has begun, and the BioAcumen Global team hopes this kit will provide much needed help locally and in the region for the surveillance and control of this new variant, Mr Toh said.